Perioperative mechanical circulatory support in children: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database.
Perioperative mechanical circulatory support in children: an analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database.
复制标题
DOI:
10.1016/j.jtcvs.2013.09.075
复制
发表时间:
2014-02
影响因子:
6
通讯作者:
Pasquali, Sara K.
中科院分区:
文献类型:
--
作者:
Mascio, Christopher E.;Austin, Erle H., III;Jacobs, Jeffrey P.;Jacobs, Marshall L.;Wallace, Amelia S.;He, Xia;Pasquali, Sara K.
Analyses of mechanical circulatory support (MCS) in pediatric heart surgery have primarily focused on single-center outcomes or narrow applications. We describe patterns of use, patient characteristics, and MCS-associated outcomes across a large multicenter cohort. Patients (<18yrs) in the STS Congenital Heart Surgery Database (2000-2010) were included. Characteristics and outcomes of those receiving post-operative MCS were described, and Bayesian hierarchical models were used to examine variation in adjusted MCS rates across institutions. Of 96,596 operations (80 centers), MCS was used in 2.4%. MCS patients were younger (13d v. 195d, p<0.0001) and more often had STS-defined preoperative risk factors (57.2% v. 32.7%, p<0.0001). Operations with the highest MCS rates included the Norwood procedure (17%) and complex biventricular repairs (arterial switch/VSD/arch repair-14%). Over half of MCS patients (53.2%) did not survive to hospital discharge (vs. 2.9%, non-MCS patients, p<0.0001). MCS-associated mortality was highest for truncus arteriosus and Ross-Konno operations (both 71%). Hospital-level MCS rates adjusted for patient characteristics and case mix varied by 15-fold across institutions; both high and low volume hospitals had substantial variation in MCS rates. Perioperative MCS use varies widely across centers. MCS rates are highest overall for the Norwood procedure and complex biventricular repairs. Although MCS can be a life-saving therapy, over half of MCS patients do not survive to hospital discharge with mortality >70% for some operations. Future studies aimed at better understanding appropriate indications, optimal timing, and management of MCS may help to reduce variation in MCS across hospitals and improve outcomes.
登录
查看更多内容
影响因子:
4.2
作者:
Conrad, SA;Rycus, PT;Dalton, H
通讯作者:
Dalton, H
影响因子:
37.8
作者:
Almond, Christopher S.;Singh, Tajinder P.;Thiagarajan, Ravi R.
通讯作者:
Thiagarajan, Ravi R.
影响因子:
3.4
作者:
Dimick, Justin B.;Staiger, Douglas O.;Birkmeyer, John D.
通讯作者:
Birkmeyer, John D.
影响因子:
4.6
作者:
Jacobs, Marshall L.;Mavroudis, Constantine;Pelletier, Glenn J.
通讯作者:
Pelletier, Glenn J.
DOI:
10.1177/2150135111426732
发表时间:
2012-01-01
影响因子:
0.9
作者:
Jacobs, Jeffrey Phillip;Jacobs, Marshall Lewis;Mayer, John E., Jr.
通讯作者:
Mayer, John E., Jr.